Alexander DeLuca, M.D.
Addiction, Pain, & Public Health website

[Home] [Library]  [Slides]  [Search]  [Medline]  [Links]
 

[Statements of Purpose, Ownership, Sponsorship. Privacy,  Email-confidentiality, and Advertising Policies]

Anesthesia-Assisted vs Buprenorphine- or Clonidine-Assisted Heroin Detoxification and Naltrexone Induction:
A Randomized Trial
[Abstract and link to Full Text PDF]

 
Eric D. Collins, Herbert D. Kleber, Robert A. Whittington, Nicole E. Heitler, JAMA, 294(8): 903-913, 2005-08-24. Posted: 2006-02-22.
[Identifier: http://www.doctordeluca.com/Library/DetoxEngage/UrodVsRod-Collins05.htm]
 
Related resources:  Detoxification and Patient Engagement archives
 
See also:
Methods of Detox and Their Role in Treating Patients With Opioid Dependence -
O'Connor, JAMA, 2005
What is Ultra-Rapid Opiate detox (UROD) and how is it different from Rapid Opiate detox (ROD)?
DeLuca, Addiction-related FAQ #18, 2000
Heroin Detoxification -
Michael M. Miller, Letter to the Editor, JAMA, 295: 885-886, 2006
War on Doctors and Pain Crisis Weekly - RSS feed:
  HTML view:
Harm Reduction for Alcohol and Drug Use Disorders Weekly - RSS feed:
  HTML view:
 

[FULL TEXT of this Article in Adobe PDF format]

ABSTRACT
Context

Rapid opioid detoxification with opioid antagonist induction using general anesthesia has emerged as an expensive, potentially dangerous, unproven approach to treat opioid dependence.

Objective
To determine how anesthesia-assisted detoxification with rapid antagonist induction for heroin dependence compared with 2 alternative detoxification and antagonist induction methods.

Design, Setting, and Patients
A total of 106 treatment-seeking heroin-dependent patients, aged 21 through 50 years, were randomly assigned to 1 of 3 inpatient withdrawal treatments over 72 hours followed by 12 weeks of outpatient naltrexone maintenance with relapse prevention psychotherapy. This randomized trial was conducted between 2000 and 2003 at Columbia University Medical Centerís Clinical Research Center. Outpatient treatment occurred at the Columbia University research service for substance use disorders. Patients were included if they had an American Society of Anesthesiologists physical status of I or II, were without major comorbid psychiatric illness, and were not dependent on other drugs or alcohol.

Interventions
Anesthesia-assisted rapid opioid detoxification with naltrexone induction, buprenorphine-assisted rapid opioid detoxification with naltrexone induction, and clonidine-assisted opioid detoxification with delayed naltrexone induction.

Main Outcome Measures
 Withdrawal severity scores on objective and subjective scales; proportions of patients receiving naltrexone, completing inpatient detoxification, and retained in treatment; proportion of opioid-positive urine specimens.

Results
Mean withdrawal severities were comparable across the 3 treatments. Compared with clonidine-assisted detoxification, the anesthesia- and buprenorphine-assisted detoxification interventions had significantly greater rates of naltrexone induction (94% anesthesia, 97% buprenorphine, and 21% clonidine), but the groups did not differ in rates of completion of inpatient detoxification. Treatment retention over 12 weeks was not significantly different among groups with 7 of 35 (20%) retained in the anesthesia-assisted group, 9 of 37 (24%) in the buprenorphine-assisted group, and 3 of 34 (9%) in the clonidine-assisted group. Induction with 50 mg of naltrexone significantly reduced the risk of dropping out (odds ratio, 0.28; 95% confidence interval, 0.15-0.51). There were no significant group differences in proportions of opioid-positive urine specimens. The anesthesia procedure was associated with 3 potentially life-threatening adverse events.

Conclusion
These data do not support the use of general anesthesia for heroin detoxification and rapid opioid antagonist induction.

[FULL TEXT of this Article in Adobe PDF format]

[END]

 

Dr. DeLuca's Addiction, Pain, and Public Health Website

Alexander DeLuca, M.D.

[Top of Page]

Originally posted: 2006-02-22

All Email to: adeluca@doctordeluca.com 

Statements of Purpose, Ownership, and Sponsorship. Privacy,  Email Confidentiality, and Advertising Policies. 

Most recently revised: 2006-02-22
Copyright @ 1998-2005. All rights reserved.

We subscribe to the HONcode principles of the HON Foundation. Click to    This website is in compliance with the HONcode. Pin # = HONConduct911193. Verify HONcode Status.   We subscribe to the HONcode principles of the HON Foundation. Click to